DrugPatentWatch Database Preview
Actavis Labs Fl Inc Company Profile
What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?
ACTAVIS LABS FL INC has seventy-one approved drugs.
There are two tentative approvals on ACTAVIS LABS FL INC drugs.
Summary for Actavis Labs Fl Inc
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 71 |
Drugs and US Patents for Actavis Labs Fl Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | DOXYCYCLINE HYCLATE | doxycycline hyclate | CAPSULE;ORAL | 062031-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Actavis Labs Fl Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077198-003 | May 13, 2010 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Actavis Labs Fl Inc | FLUTAMIDE | flutamide | CAPSULE;ORAL | 075820-001 | Sep 18, 2001 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Actavis Labs Fl Inc | CARTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 074752-001 | Jul 9, 1998 | AB3 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Actavis Labs Fl Inc | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 076470-002 | Jul 1, 2005 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Actavis Labs Fl Inc | OXYCODONE AND ASPIRIN | aspirin; oxycodone hydrochloride | TABLET;ORAL | 090084-001 | Mar 22, 2011 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Actavis Labs Fl Inc | MIRTAZAPINE | mirtazapine | TABLET;ORAL | 076336-001 | Jun 20, 2003 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
